Redox regulation in cancer stem cells

Research output: Contribution to journalArticle

Abstract

CD44 was identified as a cell surface marker for cancer stem cells (CSCs) in various epithelial tumor. However, function-based evidence to support the role of CD44 in CSCs was not known. We found that expression of CD44, in particular variant forms of CD44 (CD44v), suppresses reactive oxygen species (ROS) levels by promoting the synthesis of reduced glutathione(GSH), a primary intracellular antioxidant. CD44v stabilizes xCT, a subunit of a glutamate-cystine transporter, and thereby promotes the uptake of cystine for GSH synthesis. Our findings reveal a novel function for CD44v in protection of CSCs from high levels of ROS in the tumor microenvironment.

Original languageEnglish
Pages (from-to)790-794
Number of pages5
JournalNihon rinsho. Japanese journal of clinical medicine
Volume73
Issue number5
Publication statusPublished - 2015 May 1
Externally publishedYes

Fingerprint

Neoplastic Stem Cells
Oxidation-Reduction
Cystine
Reactive Oxygen Species
Amino Acid Transport System X-AG
Tumor Microenvironment
Glutathione
Antioxidants
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Redox regulation in cancer stem cells. / Saya, Hideyuki.

In: Nihon rinsho. Japanese journal of clinical medicine, Vol. 73, No. 5, 01.05.2015, p. 790-794.

Research output: Contribution to journalArticle

@article{8bb9308b7701453c9017d54a02797bf2,
title = "Redox regulation in cancer stem cells",
abstract = "CD44 was identified as a cell surface marker for cancer stem cells (CSCs) in various epithelial tumor. However, function-based evidence to support the role of CD44 in CSCs was not known. We found that expression of CD44, in particular variant forms of CD44 (CD44v), suppresses reactive oxygen species (ROS) levels by promoting the synthesis of reduced glutathione(GSH), a primary intracellular antioxidant. CD44v stabilizes xCT, a subunit of a glutamate-cystine transporter, and thereby promotes the uptake of cystine for GSH synthesis. Our findings reveal a novel function for CD44v in protection of CSCs from high levels of ROS in the tumor microenvironment.",
author = "Hideyuki Saya",
year = "2015",
month = "5",
day = "1",
language = "English",
volume = "73",
pages = "790--794",
journal = "Nihon rinsho. Japanese journal of clinical medicine",
issn = "0047-1852",
publisher = "Nipponrinsho Co., Inc.",
number = "5",

}

TY - JOUR

T1 - Redox regulation in cancer stem cells

AU - Saya, Hideyuki

PY - 2015/5/1

Y1 - 2015/5/1

N2 - CD44 was identified as a cell surface marker for cancer stem cells (CSCs) in various epithelial tumor. However, function-based evidence to support the role of CD44 in CSCs was not known. We found that expression of CD44, in particular variant forms of CD44 (CD44v), suppresses reactive oxygen species (ROS) levels by promoting the synthesis of reduced glutathione(GSH), a primary intracellular antioxidant. CD44v stabilizes xCT, a subunit of a glutamate-cystine transporter, and thereby promotes the uptake of cystine for GSH synthesis. Our findings reveal a novel function for CD44v in protection of CSCs from high levels of ROS in the tumor microenvironment.

AB - CD44 was identified as a cell surface marker for cancer stem cells (CSCs) in various epithelial tumor. However, function-based evidence to support the role of CD44 in CSCs was not known. We found that expression of CD44, in particular variant forms of CD44 (CD44v), suppresses reactive oxygen species (ROS) levels by promoting the synthesis of reduced glutathione(GSH), a primary intracellular antioxidant. CD44v stabilizes xCT, a subunit of a glutamate-cystine transporter, and thereby promotes the uptake of cystine for GSH synthesis. Our findings reveal a novel function for CD44v in protection of CSCs from high levels of ROS in the tumor microenvironment.

UR - http://www.scopus.com/inward/record.url?scp=84938704366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938704366&partnerID=8YFLogxK

M3 - Article

C2 - 25985632

AN - SCOPUS:84938704366

VL - 73

SP - 790

EP - 794

JO - Nihon rinsho. Japanese journal of clinical medicine

JF - Nihon rinsho. Japanese journal of clinical medicine

SN - 0047-1852

IS - 5

ER -